BioCentury | Dec 19, 2013
Financial News

Retrophin to raise $40 million, list on NASDAQ

...NASDAQ. The move follows two deals the company announced earlier this month. Retrophin is acquiring Kyalin Biosciences Inc....
BioCentury | Dec 16, 2013
Company News

Kyalin Biosciences, Retrophin, Novartis deal

...synthetic oxytocin was approved in the U.S. in 1960 to assist initial postpartum milk ejection. Kyalin Biosciences Inc....
Items per page:
1 - 2 of 2
BioCentury | Dec 19, 2013
Financial News

Retrophin to raise $40 million, list on NASDAQ

...NASDAQ. The move follows two deals the company announced earlier this month. Retrophin is acquiring Kyalin Biosciences Inc....
BioCentury | Dec 16, 2013
Company News

Kyalin Biosciences, Retrophin, Novartis deal

...synthetic oxytocin was approved in the U.S. in 1960 to assist initial postpartum milk ejection. Kyalin Biosciences Inc....
Items per page:
1 - 2 of 2